| Financier | Commitments |
|---|---|
| Asian Infrastructure Investment Bank | 100.00 |
| International Bank for Reconstruction and Development | 80.00 |
Georgia Emergency COVID-19 Response Project
Abstract*
The proposed project will support the Government of Georgia in responding to the threat posed by COVID-19 pandemic and strengthen national systems for public health preparedness in Georgia.
The Project comprises three Components: (1) Emergency COVID-19 Response; (2) Enabling health measures to contain the COVID-19 outbreak through temporary income support for poor households and vulnerable individuals, and (3) Project management and monitoring.
Component... Show More
Development Objective
The project development objective is to prevent, detect, and respond to the threat posed by the COVID-19 pandemic and strengthen national systems for public health preparedness in Georgia.
Key Details
Project Details
P173911
Closed
Christine Pena , Maddalena Honorati
Georgia
April 25, 2020
(as of board presentation)
April 30, 2020
May 28, 2020
US$ 180.00 million
Ministry of Internally Displaced Persons from the Occupied Territories, Labor, Health and Social Aff
2020
US$ 180.00 million
N/A
March 28, 2024
April 30, 2024
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 80.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 80.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | 100.00 |
| Total Project Cost** | 180.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Aug 15, 2024 | IBRD-92730 | Int Charges | 10,358.22 |
| Aug 15, 2024 | IBRD-92730 | Int Charges | 9,155.02 |
| Aug 15, 2024 | IBRD-92730 | Int Charges | 85,195.89 |
| Dec 6, 2023 | IBRD-92730 | Loan Disb | 561,899.90 |
| Jun 5, 2023 | IBRD-92730 | Loan Disb | 142,157.31 |
| Aug 15, 2023 | IBRD-92730 | Int Charges | 83,504.12 |
| Dec 28, 2020 | IBRD-91130 | Loan Disb | 1,403,437.60 |
| Feb 15, 2021 | IBRD-91130 | Int Charges | 39,206.09 |
| Feb 15, 2021 | IBRD-91130 | Int Charges | 154,008.60 |
| May 28, 2020 | IBRD-91130 | Fee Charges | 201,152.94 |
| Aug 15, 2021 | IBRD-91130 | Int Charges | 4,527.02 |
| Jul 26, 2021 | IBRD-92730 | Loan Disb | 84,607.60 |
| Jul 26, 2021 | IBRD-92730 | Fee Charges | 84,607.60 |
| May 24, 2021 | IBRD-91130 | Loan Disb | 284,952.60 |
| Apr 26, 2021 | IBRD-91130 | Loan Disb | 5,277,698.00 |
| May 10, 2021 | IBRD-91130 | Loan Disb | 28,784.82 |
| Feb 17, 2021 | IBRD-91130 | Loan Disb | 118,104.29 |
| Dec 22, 2020 | IBRD-91130 | Loan Disb | 23,076.46 |
| Jan 4, 2021 | IBRD-91130 | Loan Disb | 9,619,923.00 |
| Jan 4, 2021 | IBRD-91130 | Loan Disb | 7,486,637.00 |
| Feb 22, 2021 | IBRD-91130 | Loan Disb | 4,634,963.50 |
| Aug 15, 2023 | IBRD-92730 | Int Charges | 796.72 |
| Jun 28, 2023 | IBRD-91130 | Loan Disb | 284,771.20 |
| Feb 15, 2023 | IBRD-91130 | Int Charges | 3,962.87 |
| Feb 15, 2023 | IBRD-91130 | Int Charges | 772,026.00 |
| Feb 15, 2023 | IBRD-92730 | Int Charges | 6.26 |
| Feb 15, 2023 | IBRD-92730 | Int Charges | 3,745.83 |
| Feb 15, 2023 | IBRD-92730 | Int Charges | 303.57 |
| Feb 15, 2023 | IBRD-92730 | Int Charges | 133,869.81 |
| Aug 15, 2023 | IBRD-92730 | Loan Disb | -272,843.25 |
| Aug 15, 2023 | IBRD-92730 | Loan Disb | 272,843.25 |
| Dec 30, 2021 | IBRD-92730 | Loan Disb | 1,314,170.00 |
| Dec 3, 2021 | IBRD-91130 | Loan Disb | 1,426,958.90 |
| Aug 15, 2022 | IBRD-92730 | Int Charges | 292.83 |
| May 2, 2024 | IBRD-91130 | Loan Disb | 64,682.81 |
| Feb 15, 2024 | IBRD-92730 | Loan Disb | -559,606.40 |
| Aug 15, 2024 | IBRD-91130 | Int Charges | 866,574.06 |
| Aug 15, 2024 | IBRD-91130 | Int Charges | 100.93 |
| Aug 15, 2024 | IBRD-91130 | Int Charges | 972,790.10 |
| Aug 15, 2024 | IBRD-92730 | Int Charges | 5,583.88 |
| May 28, 2020 | IBRD-91130 | Loan Disb | 201,152.94 |
| Nov 17, 2020 | IBRD-91130 | Loan Disb | 5,222,498.50 |
| Jul 2, 2020 | IBRD-91130 | Loan Disb | 27,612,216.00 |
| Aug 15, 2020 | IBRD-91130 | Int Charges | 511.50 |
| Oct 2, 2020 | IBRD-91130 | Loan Disb | 4,188,805.20 |
| Dec 7, 2020 | IBRD-91130 | Loan Disb | 2,641,290.80 |
| Jan 22, 2021 | IBRD-91130 | Loan Disb | 248,663.81 |
| Mar 14, 2022 | IBRD-92730 | Loan Disb | 205,844.50 |
| Dec 16, 2021 | IBRD-91130 | Loan Disb | 1,825,339.80 |
| Feb 15, 2022 | IBRD-91130 | Int Charges | 332.73 |
| Feb 15, 2022 | IBRD-91130 | Int Charges | 9,432.15 |
| Feb 15, 2022 | IBRD-91130 | Int Charges | 275,437.88 |
| Feb 15, 2022 | IBRD-92730 | Int Charges | 9.96 |
| Feb 15, 2022 | IBRD-92730 | Int Charges | 2,403.47 |
| Feb 15, 2022 | IBRD-92730 | Int Charges | 345.98 |
| Feb 15, 2022 | IBRD-91130 | Int Charges | 130.12 |
| Mar 31, 2022 | IBRD-92730 | Loan Disb | 5,376,168.50 |
| May 5, 2022 | IBRD-92730 | Loan Disb | 2,887.62 |
| Jul 6, 2022 | IBRD-92730 | Loan Disb | 24,360.38 |
| Mar 28, 2022 | IBRD-92730 | Loan Disb | 488,236.90 |
| Mar 28, 2022 | IBRD-92730 | Loan Disb | 297,652.56 |
| Sep 24, 2021 | IBRD-91130 | Loan Disb | 274,457.97 |
| Aug 16, 2021 | IBRD-91130 | Loan Disb | 3,341,374.50 |
| Aug 16, 2021 | IBRD-91130 | Loan Disb | 365,897.62 |
| Aug 15, 2021 | IBRD-92730 | Loan Disb | -84,299.08 |
| Aug 15, 2021 | IBRD-92730 | Loan Disb | 84,299.08 |
| Aug 10, 2021 | IBRD-91130 | Loan Disb | 722,078.20 |
| Nov 29, 2021 | IBRD-92730 | Loan Disb | 996,047.75 |
| Oct 13, 2021 | IBRD-92730 | Loan Disb | 2,890,375.00 |
| Aug 31, 2021 | IBRD-91130 | Loan Disb | 366,668.90 |
| Aug 9, 2021 | IBRD-91130 | Loan Disb | 338,119.78 |
| May 20, 2021 | IBRD-91130 | Loan Disb | 160,040.81 |
| May 20, 2021 | IBRD-91130 | Loan Disb | 1,888,083.90 |
| May 7, 2021 | IBRD-91130 | Loan Disb | 221,027.45 |
| Jun 17, 2021 | IBRD-91130 | Loan Disb | 309,686.70 |
| Sep 7, 2021 | IBRD-91130 | Loan Disb | 243,430.47 |
| Aug 15, 2021 | IBRD-91130 | Int Charges | 248,289.69 |
| Aug 18, 2021 | IBRD-91130 | Loan Disb | 18,935.47 |
| Aug 15, 2021 | IBRD-91130 | Int Charges | 17,308.50 |
| Aug 15, 2023 | IBRD-92730 | Int Charges | 8,992.69 |
| Aug 15, 2023 | IBRD-92730 | Int Charges | 165.99 |
| Sep 1, 2023 | IBRD-91130 | Loan Disb | 296,681.78 |
| Aug 15, 2023 | IBRD-92730 | Int Charges | 136,656.94 |
| Aug 15, 2023 | IBRD-91130 | Int Charges | 5.70 |
| Aug 15, 2023 | IBRD-91130 | Int Charges | 40.73 |
| Aug 15, 2023 | IBRD-92730 | Int Charges | 9,561.07 |
| Aug 15, 2023 | IBRD-92730 | Int Charges | 2,362.42 |
| Aug 15, 2023 | IBRD-92730 | Int Charges | 309.89 |
| Aug 15, 2023 | IBRD-91130 | Int Charges | 1,212.93 |
| Aug 15, 2023 | IBRD-91130 | Int Charges | 1,725,035.00 |
| Feb 15, 2023 | IBRD-92730 | Loan Disb | 474,831.56 |
| May 11, 2023 | IBRD-92730 | Loan Disb | 127,353.73 |
| Feb 15, 2023 | IBRD-92730 | Loan Disb | -474,831.56 |
| Feb 15, 2023 | IBRD-92730 | Int Charges | 83,156.86 |
| Mar 2, 2023 | IBRD-91130 | Loan Disb | 20,924.98 |
| Mar 22, 2023 | IBRD-91130 | Loan Disb | 24,088.04 |
| Nov 18, 2022 | IBRD-91130 | Loan Disb | 492,807.66 |
| Jan 4, 2023 | IBRD-91130 | Loan Disb | 19,203.05 |
| Dec 27, 2022 | IBRD-92730 | Loan Disb | 472,349.00 |
| Nov 21, 2022 | IBRD-91130 | Loan Disb | 3,221,454.80 |
| Jan 7, 2022 | IBRD-92730 | Loan Disb | 54,512.50 |
| Feb 15, 2022 | IBRD-92730 | Loan Disb | -17,293,444.00 |
| Feb 15, 2022 | IBRD-92730 | Loan Disb | 17,293,444.00 |
| Feb 7, 2022 | IBRD-92730 | Loan Disb | 12,189,003.00 |
| Aug 15, 2022 | IBRD-91130 | Int Charges | 688.91 |
| Aug 15, 2022 | IBRD-92730 | Int Charges | 802.83 |
| Aug 15, 2022 | IBRD-92730 | Int Charges | 4,946.38 |
| Aug 15, 2022 | IBRD-92730 | Int Charges | 128,310.75 |
| Aug 15, 2022 | IBRD-91130 | Int Charges | 1,322.72 |
| Aug 15, 2022 | IBRD-91130 | Int Charges | 5,870.92 |
| Aug 15, 2022 | IBRD-91130 | Int Charges | 277,462.47 |
| Aug 15, 2022 | IBRD-92730 | Loan Disb | -5,893,420.50 |
| Aug 15, 2022 | IBRD-92730 | Loan Disb | 5,893,420.50 |
| Apr 30, 2020 | IBRD-91130 | Loan Commitment | 80,000,000.00 |
| Jun 7, 2021 | IBRD-92730 | Loan Commitment | 34,500,000.00 |
| May 10, 2024 | IBRD-91130 | Loan Disb | 78,790,832.00 |
| May 10, 2024 | IBRD-91130 | Loan Disb | -78,790,832.00 |
| Feb 15, 2024 | IBRD-92730 | Int Charges | 285.04 |
| Feb 15, 2024 | IBRD-92730 | Int Charges | 130,091.33 |
| Mar 7, 2024 | IBRD-91130 | Loan Disb | 302,078.53 |
| Jul 16, 2024 | IBRD-92730 | Loan Disb | 14,173.01 |
| Feb 15, 2024 | IBRD-92730 | Int Charges | 8,854.58 |
| Feb 15, 2024 | IBRD-92730 | Int Charges | 81,766.32 |
| Feb 15, 2024 | IBRD-92730 | Int Charges | 5,408.65 |
| Feb 15, 2024 | IBRD-92730 | Int Charges | 9,082.23 |
| Feb 15, 2024 | IBRD-92730 | Int Charges | 5,021.69 |
| Feb 15, 2024 | IBRD-91130 | Int Charges | 1,526.90 |
| Feb 15, 2024 | IBRD-91130 | Int Charges | 607.95 |
| Feb 15, 2024 | IBRD-91130 | Int Charges | 2,065,026.40 |
| Feb 15, 2024 | IBRD-91130 | Int Charges | 91.75 |
| Feb 15, 2024 | IBRD-92730 | Loan Disb | 559,606.40 |
| Mar 20, 2024 | IBRD-91130 | Loan Disb | 93,876.93 |
| Aug 15, 2024 | IBRD-92730 | Loan Disb | -14,318.00 |
| Aug 15, 2024 | IBRD-92730 | Loan Disb | 14,318.00 |
| Aug 15, 2024 | IBRD-92730 | Int Charges | 8,752.79 |
| Aug 15, 2024 | IBRD-92730 | Int Charges | 319.94 |
| Aug 15, 2024 | IBRD-92730 | Int Charges | 139,291.27 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Procurement | Moderately Satisfactory | 2024-09-03 |
| Project Management | Satisfactory | 2024-09-03 |
| Progress towards achievement of PDO | Satisfactory | 2024-09-03 |
| Financial Management | Satisfactory | 2024-09-03 |
| Monitoring and Evaluation | Satisfactory | 2024-09-03 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-09-03 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-09-03 |
| Progress towards achievement of PDO | Satisfactory | 2024-09-03 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of people tested for COVID-19 identification per MoILHSA protocol Value 9699.00 20379484.00 100000.00 Date April 24, 2020 May 31, 2023 April 30, 2024 Comment Number of COVID-19 patients treated per SSA reimbursement guidelines. Value 431.00 296605.00 2000.00 Date April 24, 2020 May 31, 2023 April 30, 2024 Comment Share of the population in the poorest quintile who are receiving the COVID-19 pandemic related social assistance programs. Value 36.00 62.60 45.00 Date April 16, 2020 September 30, 2022 April 30, 2024 Comment Percentage of the population vaccinated, which are included in the priority population targets defined in the national plan: (a) Males; and (b) Females Value (a) 0.8%(b) 0.8% (a) 45% (b) 53% (a) 35%(b) 50% Date March 12, 2021 May 31, 2023 April 30, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of vulnerable households receiving temporary cash benefit. Value 0.00 108577.00 70000.00 Date April 16, 2020 September 30, 2022 April 30, 2024 Comment Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents per MOILHSA guidelines. Value 0.00 38.00 32.00 Date April 16, 2020 May 31, 2023 April 30, 2024 Comment Percentage of beneficiaries reporting that community engagement and outreach meet their needs. Value 0.00 85.00 70.00 Date April 16, 2020 June 30, 2022 April 30, 2024 Comment Number of formal private sector workers laid off because of COVID-related lock down who receive temporary unemployment benefits, by gender. Value 0.00 239508.00 135000.00 Date April 16, 2020 January 14, 2022 April 30, 2024 Comment Number of personal protection equipment (PPE) purchased. Value 0.00 17374000.00 12000000.00 Date April 16, 2020 September 30, 2022 April 28, 2023 Comment Number of TSA beneficiary households. Value 108504.00 121955.00 124000.00 Date March 31, 2020 September 30, 2022 April 30, 2024 Comment Number of designated public hospitals with fully equipped and functional intensive care units (ICUs) for COVID-19 patients Value 0.00 4.00 4.00 Date April 30, 2020 May 31, 2023 May 1, 2024 Comment Complaints received related to COVID-related social assistance programs. Value 0.00 0.00 5.00 Date April 16, 2020 September 30, 2022 April 30, 2024 Comment Number of designated public hospitals with isolation capacity. Value 0.00 4.00 4.00 Date April 16, 2020 May 31, 2023 April 30, 2024 Comment Number of informal workers who receive the one-off benefit , by gender Value 0.00 368693.00 340000.00 Date April 16, 2020 September 30, 2022 April 30, 2024 Comment Review of the VIRAT-VRAF 2.0 or updated tool, completed Value No Yes Yes Date April 15, 2021 September 30, 2022 April 30, 2024 Comment Percentage of female beneficiaries of the unemployment benefit among all unemployment beneficiaries Value 0.00 55.05 56.00 Date April 1, 2020 September 30, 2022 April 30, 2024 Comment Number of eligible COVID-19 vaccines procured Value 0.00 3825170.00 2474000.00 Date March 12, 2021 September 30, 2022 April 30, 2024 Comment Percentage of female beneficiaries of temporary cash benefit among all temporary cash beneficiaries Value 0.00 45.00 56.00 Date April 1, 2020 September 30, 2022 April 30, 2024 Comment Percentage of reported AEFIs that are investigated and managed in line with the national protocol Value 0.00 100.00 80.00 Date March 12, 2021 May 31, 2023 April 30, 2024 Comment Percentage of individuals that will accept a safe and effective COVID-19 vaccine: (a) Males; and (b) Females Value a-) 48.6%b-) 48.0% a-) 33.5% b-) 31.2% a-) 60%b-) 60% Date April 14, 2021 September 30, 2022 April 30, 2024 Comment